The National Institutes of Allergy and Infectious Diseases (NIAID) is soliciting for continued development of decorporation agents used to treat internal exposure of radiation, which occurs when radionuclides are internalized by inhalation, ingestion, or through contaminated wounds and distributed to sensitive tissues. NIAID expects to award two work assignment type contracts that would last for five years. Contracts would be awarded next fall. Sol. No. RFP-NIH-NIAID-DAIT-BARDA-08-09. Respond by Dec. 5. Contact: Wanda Neal, contracting officer, 301-451-3685, [email protected].
free preview